75%

Symptom improvement rate observed in clinical data for refractory migraine patients receiving low-dose IV ketamine (PubMed/NCBI)

1 Billion

People worldwide affected by migraines, making it one of the leading causes of neurological disability (WHO)

39M

Americans living with chronic or episodic migraine attacks (American Migraine Foundation)

Advanced Interventions

Offering IV Ketamine, TMS Therapy, and Spravato® for treatment-resistant migraines (Oxford Academic)

FDA Status & Regulatory Context

Advanced interventional migraine care combines FDA-approved standard therapies with evidence-based off-label modalities. Standard acute and preventive treatments, such as triptans, anticonvulsants, and CGRP inhibitors, hold primary FDA approval for episodic and chronic migraine management. For patients with refractory pain or status migrainosus, Transcranial Magnetic Stimulation (TMS Therapy), low-dose IV Ketamine infusions, and Spravato® (Esketamine) nasal spray offer additional evidence-based options, each used here off-label for migraine, separate from their own FDA-cleared or FDA-approved indications, when conventional oral and injectable medications fail to deliver sufficient relief.

Advanced Interventional Modalities for Migraines

IV Ketamine Infusion Therapy

For patients trapped in status migrainosus (a severe migraine lasting more than 72 hours) or chronic refractory pain, low-dose IV Ketamine offers a rapid-acting intervention. Ketamine blocks N-methyl-D-aspartate (NMDA) glutamate receptors in the central nervous system, resetting hypersensitized pain pathways, reducing neuroinflammation, and disrupting intractable pain signals when conventional acute drugs fail.

Transcranial Magnetic Stimulation (TMS Therapy)

Transcranial Magnetic Stimulation (TMS) is a non-invasive neuromodulation therapy, FDA-cleared for the treatment of depression and OCD. Used here as an evidence-based, off-label option for migraine, TMS delivers targeted magnetic pulses to the cerebral cortex to help calm cortical hyperexcitability and modulate the pain pathways associated with migraine. It requires no sedation, avoids systemic medication side effects, and allows patients to resume daily activities immediately after each session.

Spravato® (Esketamine) Nasal Spray

When chronic migraines are compounded by severe treatment-resistant depression or chronic pain-induced mood crises, Spravato® — FDA-approved for treatment-resistant depression — provides an in-clinic nasal spray protocol used here to help manage the depression that often compounds chronic migraine. By enhancing synaptic plasticity and glutamate signaling, Spravato helps alleviate severe depressive weight while supporting overall neurological recovery.

Specialized Medication Management

Finding the right preventive regimen requires expert pharmacological navigation. Our clinical prescribers continuously evaluate, fine-tune, and optimize oral or injectable regimens, including CGRP antagonists, beta-blockers, and anticonvulsants, to prevent rebound headaches and minimize drug interactions.

What the Migraine Care Journey Looks Like

01

Free Consultation & Diagnostic Evaluation

Reach us at (954) 320-4944 or online. Our clinical team evaluates your headache history, attack frequency, prior medication failures, and health goals.

02

Custom Interventional Planning

We collaborate with you to design a personalized treatment protocol, combining IV Ketamine, TMS Therapy, Spravato, or Medication Optimization based on your specific clinical presentation.

03

Clinical Treatment Administration

Receive care in a calm, controlled environment, whether attending a 20-minute daily TMS session, relaxing in a private suite during a monitored 45-minute IV ketamine infusion, or receiving supervised Spravato administration.

04

Progress Tracking & Pain Mapping

We track attack frequency, intensity, and duration using standardized headache impact tests (e.g., HIT-6), adjusting your protocol to maximize pain-free days.

05

Maintenance & Prevention

Periodic booster sessions, preventive medication tuning, or ongoing TMS maintenance help lock in neurological gains and prevent future refractory flare-ups.

Comparing Migraine Treatment Options

Feature

Primary Mechanism

Therapeutic Target

Administration

Anesthesia / Sedation

Driving Afterward

Best Suited For

Insurance Coverage

Standard Oral Medications (Triptans/NSAIDs)

Serotonin receptor agonism / Inflammation reduction

Acute pain relief / Mild prevention

Daily oral pills or acute nasal sprays

None

Yes

Episodic, mild-to-moderate migraines

Usually covered

CGRP Antagonists (Injectables/Oral)
Transcranial

Calcitonin gene-related peptide inhibition

Monthly prevention / Acute relief

Monthly injections or daily oral pills

None

Yes

First-line chronic prevention

Usually covered with prior auth

Magnetic Stimulation (TMS)

Magnetic cortical neuromodulation

Cortical hyperexcitability modulation (off-label for migraine)

Daily 20-min in-clinic sessions

None (Fully awake)

Yes (Drive immediately)

Non-drug neurological modulation

Typically self-pay for migraine use

IV Ketamine Therapy

NMDA glutamate receptor antagonist

Central sensitization & pain pathway reset

Monitored IV infusion in private suite

Mild dissociation / relaxation

No (Driver required)

Status migrainosus & refractory pain

Osmind claims assistance

Spravato® (Esketamine)

NMDA glutamate receptor antagonist

Rapid neuroplasticity & mood modulation

Supervised in-clinic nasal spray

Mild dissociation / sedation

No (Driver required)

Migraines co-occurring with severe TRD

Covered by most major plans

Why Choose Advanced Interventions Over Standard Treatments

Over Standard Medications Alone: Conventional acute medications often lead to “medication overuse headaches” (rebound migraines) when taken frequently. Advanced interventional modalities like IV Ketamine and TMS treat central nervous system hypersensitivity directly without causing rebound pain.

Rapid Relief for Severe Attacks: While oral preventives can take 2 to 3 months to demonstrate efficacy, low-dose IV Ketamine can disrupt severe, ongoing status migrainosus within hours to days.

Comprehensive Multi-Modal Approach: Rather than relying on a single pill, Ketamine Wellness Clinic integrates physical brain stimulation (TMS), central pain resets (Ketamine), FDA-approved nasal sprays (Spravato), and expert psychopharmacology for lasting relief.

Frequently Asked Questions About Migraine Treatment

How does IV Ketamine help stop a severe or refractory migraine?

Ketamine acts as an NMDA receptor antagonist, interrupting central sensitization, the process where the brain and spinal cord become overly sensitive to pain signals. By resetting these pathways, ketamine can rapidly break severe status migrainosus and intractable migraine cycles.

Yes — TMS has an established safety profile from its FDA-cleared use in depression and OCD. For migraine specifically, it’s offered here as an evidence-based, off-label option: magnetic pulses are used to calm hyperactive cortical neurons and help ease the pain and aura activity associated with migraine attacks.

You can drive home immediately following TMS Therapy sessions. For IV Ketamine and Spravato sessions, safety guidelines require an adult driver or ride service to transport you home due to transient dissociative or sedative effects.

Not necessarily. Many patients utilize interventional treatments to break acute pain cycles or reduce attack frequency, allowing them to lower their reliance on daily oral medications under medical supervision.

A standard protocol for refractory migraine typically consists of an initial series of 3 to 6 targeted infusions, followed by periodic maintenance sessions as needed based on your individual pain relief duration.

When conventional acute and preventive drugs fail, our clinical team evaluates you for advanced interventional options, including IV Ketamine infusions, TMS Therapy, or Spravato protocols tailored to your pain profile.

Find Out More

Contact us today and learn how Ketamine Clinic can guide your personal wellness journey.

By Appointment Only

Pompano Beach

41 N Federal Hwy, Suite A, 2nd Floor Pompano Beach, FL 33062

(954) 320-4944

(954) 400-5805

contact@ketamineclinicsouthflorida.com